DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Loomba R, Kayali Z, Noureddin M. et al.
GS-0976 reduces hepatic steatosis and fibrosis markers in patients with nonalcoholic fatty liver disease.
Gastroenterology 2018;
155 (05) 1463-1473.e6
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.